Výsledky vyhledávání - "V. Novakivskyy"

Akademický článek

One year of the full-scale war in Ukraine and kidney replacement therapy: Where do we stand now? A brief report of the Ukrainian Renal Disaster Relief Committee of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists

Autor: M. Kolesnyk, I. Dudar, N. Stepanova, O. Loboda, I. Shifris, Y. Honchar, E. Krasyuk, V. Novakivskyy, S. Fomina, N. Kozliuk, O. Razvazhaeva

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 1(77) (2023)

The war in Ukraine is now entering its ninth year, and a year has passed since the russian army invaded Ukraine on a large scale. A few months ago, the Ukrainian Renal Disaster Relief Committee of the Ukrainian Association of Nephrologists and Kidney

Externí odkaz: https://doaj.org/article/fa9fc692d4eb43b08f9d010611412d55

Zobrazit plný text záznamu

Akademický článek

Recommendations of the Ukrainian Renal Disaster Relief Committee of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists regarding medical care to kidney disease patients during the war

Autor: M. Kolesnyk, I. Dudar, N. Stepanova, V. Novakivskyy, Y. Honchar, E. Krasyuk, I. Shifris, R. Zograbian, M. Velychko, O. Loboda, S. Fomina

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 3(75) (2022)

Abstract. The occurrence of an emergency situation (ES) forced international (ISN, EDTA/ERA) and national (Turkey) nephrological associations to establish the Renal Disaster Relief Task Force, which is primarily concerned with the treatment of patien

Externí odkaz: https://doaj.org/article/06422658753d40489658415f4c02e5f8

Zobrazit plný text záznamu

Akademický článek

Anemia and the use of antihypertensive medications in hemodialysis patients: multicenter retrospective observational study

Autor: N. Stepanova, V. Novakivskyy, L. Snisar, M. Kutsenko

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 1(61) (2019)

Abstract. We hypothesized that the use of antihypertensive medications in patients treated by hemodialysis (HD) may interfere with the activity of erythropoietin and leads to an increase in the dose of erythropoiesis stimulating agents (ESAs). The

Externí odkaz: https://doaj.org/article/78c9abbe8ecc46eab0827b2c153668d9

Zobrazit plný text záznamu

Akademický článek

The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients

Autor: N. Stepanova, L. Korol, V. Novakivskyy, M. Kolesnyk

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 3(59) (2018)

At present, there have been no reports on the dose-dependent effects of continuous erythropoietin receptor activator(CERA) therapy on oxidative stress and red blood cell membrane lipid peroxidation parameters in hemodialysis (HD) patients. The aim

Externí odkaz: https://doaj.org/article/05589402f7f44b46b38ffbd67ee6a713

Zobrazit plný text záznamu

Akademický článek

PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION

Autor: V. Novakivskyy

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 1(53) (2017)

Anemia is an integral component of CKD. The prescribing of erythropoiesis stimulating agents (ESA) for the treatment of anemia constitutes a significant burden on health budgets. Using of continuous erythropoietin receptor activator (CERA) and convec

Externí odkaz: https://doaj.org/article/10a072c5ed9b4a0ca9c68514e3a475a1

Zobrazit plný text záznamu

Akademický článek

INDICATORS OF OXIDATIVE STRESS AND RESISTANCE OF ERYTHROCYTES IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE VD DEPENDING ON MODALITY OF RENAL REPLACEMENT THERAPY

Autor: M. Kolesnyk, L. Korol, L. Migal, O. Burdeyna, V. Novakivskyy

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 3(47) (2015)

The object was to study the effect of oxidative factors and methods of renal replacement therapy (RRT) on indices of oxidative stress (OS) and resistance cells in blood in patients with chronic kidney disease stage V(CKD VD) and anemic syndrome. M

Externí odkaz: https://doaj.org/article/925df3494671452fabde1b8bee107d19

Zobrazit plný text záznamu

Akademický článek

CLINICAL AND ECONOMIC ANALYSIS OF USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR THE TREATMENT OF ANEMIA CKD V HD PATIENTS

Autor: M. Kolesnyk, N. Bezdetko, V. Novakivskyy

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 3(47) (2015)

The article describes the ways to cost optimization of anemia treatment CKD - HD patients. Aims. dinical and economic analysis treatment of Anemia CKD VHD PTS with using long action Erythropoiesis Stimulating Agents (ESA). Methods. We calculate

Externí odkaz: https://doaj.org/article/4e91e51323394c5cb6f6585a4a2d5e7b

Zobrazit plný text záznamu

Akademický článek

USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASES V D ST

Autor: M. Kolesnyk, M. Kulyzkyp, Y. Busygina, A. Bilenko, V. Novakivskyy

Publikováno v: Український Журнал Нефрології та Діалізу, Iss 4(44) (2014)

the article describes approaches to cost optimization of anemia treatment in CKD–VDst. patients by comparison of costs in phase correction and support treatment with long action ESA in patients on HD and HDF. Aims. To reveal the influence of HD

Externí odkaz: https://doaj.org/article/08faaca9358b48eab1c2d7f437a242c5

Zobrazit plný text záznamu